← Open Payments lookup

BORIS FURMAN: Open Payments

NPI 1164695011 · MANALAPAN, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,900 in 115 payments from 26 companies in 2025. Trend: 2023 $1,839 · 2024 $1,757 · 2025 $1,900

Food & beverage: $1,884Speaker / faculty: $16
CompanyPaymentsAmount
ABBVIE INC.25$302
Neurocrine BioSciences, Inc.10$201
Teva Pharmaceuticals USA, Inc.15$179
Lilly USA, LLC8$136
Eisai Inc.8$135
Averitas Pharma Inc.5$104
PFIZER INC.5$91
Lundbeck LLC5$90
Novartis Pharmaceuticals Corporation3$73
ARGENX US, INC.4$67

Products named: INGREZZA, AUSTEDO XR, UBRELVY, QULIPTA, Leqembi, AMYVID, QUTENZA, KESIMPTA.

Industry payments across NJ — which companies pay providers there.